Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
- PMID: 28418296
- PMCID: PMC5403029
- DOI: 10.3201/eid2305.161477
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Abstract
China's hepatitis B virus (HBV) prevention policy has been evaluated through nationally representative serologic surveys conducted in 1992 and 2006. We report results of a 2014 serologic survey and reanalysis of the 1992 and 2006 surveys in the context of program policy. The 2014 survey used a 2-stage sample strategy in which townships were selected from 160 longstanding, nationally representative, county-level disease surveillance points, and persons 1-29 years of age were invited to participate. The 2014 sample size was 31,713; the response rate was 83.3%. Compared with the 1992 pre-recombinant vaccine survey, HBV surface antigen prevalence declined 46% by 2006 and by 52% by 2014. Among children <5 years of age, the decline was 97%. China's HBV prevention program, targeted toward interrupting perinatal transmission, has been highly successful and increasingly effective. However, this progress must be sustained for decades to come, and elimination of HBV transmission will require augmented strategies.
Keywords: China; hepatitis B; immunization; vaccination; vaccine; viruses.
Figures
Similar articles
-
A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.Int J Epidemiol. 2000 Aug;29(4):744-52. doi: 10.1093/ije/29.4.744. Int J Epidemiol. 2000. PMID: 10922354
-
Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.MMWR Morb Mortal Wkly Rep. 2007 May 11;56(18):441-5. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17495790
-
Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.J Infect Dis. 2000 Feb;181(2):413-8. doi: 10.1086/315259. J Infect Dis. 2000. PMID: 10669320
-
Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.Int J Infect Dis. 2012 Feb;16(2):e82-8. doi: 10.1016/j.ijid.2011.10.009. Epub 2011 Dec 17. Int J Infect Dis. 2012. PMID: 22178658 Review.
-
Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.Epidemiol Rev. 2006;28:126-35. doi: 10.1093/epirev/mxj010. Epub 2006 Jun 16. Epidemiol Rev. 2006. PMID: 16782778 Review.
Cited by
-
New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020.Lancet Reg Health West Pac. 2024 Sep 14;51:101193. doi: 10.1016/j.lanwpc.2024.101193. eCollection 2024 Oct. Lancet Reg Health West Pac. 2024. PMID: 39315090 Free PMC article.
-
Impact of Hepatitis B Virus Point-of-care DNA Viral Load Testing Compared With Laboratory-based Standard-of-care Approaches on Uptake of HBV Viral Load Testing, Treatment, and Turnaround Times: A Systematic Review and Meta-analysis.Open Forum Infect Dis. 2024 Aug 26;11(9):ofae483. doi: 10.1093/ofid/ofae483. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39296343 Free PMC article.
-
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges.Front Immunol. 2024 Sep 2;15:1429836. doi: 10.3389/fimmu.2024.1429836. eCollection 2024. Front Immunol. 2024. PMID: 39286246 Free PMC article. Review.
-
Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study.JMIR Public Health Surveill. 2024 Sep 4;10:e60021. doi: 10.2196/60021. JMIR Public Health Surveill. 2024. PMID: 39230944 Free PMC article.
-
Trends and multi-model prediction of hepatitis B incidence in Xiamen.Infect Dis Model. 2024 Aug 6;9(4):1276-1288. doi: 10.1016/j.idm.2024.08.001. eCollection 2024 Dec. Infect Dis Model. 2024. PMID: 39224908 Free PMC article.
References
-
- World Health Organization. Hepatitis B [cited 2015 Nov 16]. http://www.who.int/mediacentre/factsheets/fs204/en
-
- Li Y. Epidemiology of virus hepatitis in China. Chinese Journal of Microbiology and Immunology. 1986;Suppl (Viral Hepatitis):1–14.
-
- Dai Z, Qi G. Virus hepatitis in China: seroepidemiological survey in Chinese population (part one) 1992–1995. Beijing: Beijing Science and Technology Literature Press; 1996. p. 8–103.
-
- Qu Z. Epidemiological study on the distribution of HBsAg and anti-HBs in China. Chinese Journal of Microbiology and Immunology. 1986;Suppl (Viral Hepatitis):20–40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical